Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Potassium-Sparing Diuretic Therapy with Triamterene

Clinical Uses and Efficacy

  • The American Heart Association recommends triamterene in combination with thiazide diuretics to prevent hypokalemia while maintaining antihypertensive efficacy in patients with hypertension 1
  • The European Society of Cardiology suggests using triamterene as add-on therapy in patients being treated with drugs from other antihypertensive classes, with a usual maintenance dose of 1-2 mg/kg/day up to 300 mg/day 3, 4
  • The American Academy of Pediatrics recommends an initial dose of 1-2 mg/kg/day with a maximum dose of 3-4 mg/kg/day up to 300 mg/day in pediatric patients 3, 4

Contraindications and Precautions

  • The American College of Cardiology advises against using triamterene in patients with significant renal dysfunction (GFR <45 mL/min) due to the risk of hyperkalemia 1
  • The European Society of Cardiology recommends avoiding concurrent use of triamterene with other potassium-sparing diuretics due to the increased risk of hyperkalemia 2

Drug Interactions

  • The American Heart Association warns of an increased risk of hyperkalemia when triamterene is used with ACE inhibitors or ARBs, and recommends monitoring potassium levels closely 1, 4